WS7.3 Once-daily liposomal amikacin for inhalation is noninferior to twice-daily tobramycin inhalation solution in improving pulmonary function in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa

✍ Scribed by Bilton, D.; Pressler, T.; Fajac, I.; Clancy, J.P.; Sands, D.; Minic, P.; Cipolli, M.; La Rosa, M.; Galeva, I.; Solé, A.; Dupont, L.; Goss, C.H.; Mayer-Hamblett, N.; Quittner, A.L.; Constantine, S.; Gupta, R.; Konstan, M.

• Book ID: 124112747
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 65 KB
• Volume: 13
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/S1569-1993(14)60048-5